Improving QoL through the use of STAT-ON™. حسب Daniel Rodriguez-Martin (22411006)

"…While medication costs may increase, overall direct healthcare expenses decrease, leading to net savings. …"

Experiments (Crystal violet assay). حسب Takanori Kitagawa (20727226)

"…The concentration of radical adducts in H₂O in a tube exposed to YCW-H with Fe(III) ions further increased to 0.51 μmol/L, indicating that the growth inhibition was correlated with the increased RCS levels. …"

Experiments (Crystal violet assay). حسب Takanori Kitagawa (20727226)

"…The concentration of radical adducts in H₂O in a tube exposed to YCW-H with Fe(III) ions further increased to 0.51 μmol/L, indicating that the growth inhibition was correlated with the increased RCS levels. …"

FCM analysis (%). حسب Takanori Kitagawa (20727226)

"…The concentration of radical adducts in H₂O in a tube exposed to YCW-H with Fe(III) ions further increased to 0.51 μmol/L, indicating that the growth inhibition was correlated with the increased RCS levels. …"

Experiments (Crystal violet assay). حسب Takanori Kitagawa (20727226)

"…The concentration of radical adducts in H₂O in a tube exposed to YCW-H with Fe(III) ions further increased to 0.51 μmol/L, indicating that the growth inhibition was correlated with the increased RCS levels. …"

Experiments (Crystal violet assay). حسب Takanori Kitagawa (20727226)

"…The concentration of radical adducts in H₂O in a tube exposed to YCW-H with Fe(III) ions further increased to 0.51 μmol/L, indicating that the growth inhibition was correlated with the increased RCS levels. …"

Scenario 1. Moderate patient with STAT-ON™. حسب Daniel Rodriguez-Martin (22411006)

"…While medication costs may increase, overall direct healthcare expenses decrease, leading to net savings. …"

ESR Data for حسب Takanori Kitagawa (20727226)

"…The concentration of radical adducts in H₂O in a tube exposed to YCW-H with Fe(III) ions further increased to 0.51 μmol/L, indicating that the growth inhibition was correlated with the increased RCS levels. …"

Scenario 2. Advanced patient with STAT-ON™. حسب Daniel Rodriguez-Martin (22411006)

"…While medication costs may increase, overall direct healthcare expenses decrease, leading to net savings. …"

Experiments (Crystal violet assay). حسب Takanori Kitagawa (20727226)

"…The concentration of radical adducts in H₂O in a tube exposed to YCW-H with Fe(III) ions further increased to 0.51 μmol/L, indicating that the growth inhibition was correlated with the increased RCS levels. …"

Live/Dead cells 4 days incubation. حسب Takanori Kitagawa (20727226)

"…The concentration of radical adducts in H₂O in a tube exposed to YCW-H with Fe(III) ions further increased to 0.51 μmol/L, indicating that the growth inhibition was correlated with the increased RCS levels. …"

ESR Fig 4, Table 1 data. حسب Takanori Kitagawa (20727226)

"…The concentration of radical adducts in H₂O in a tube exposed to YCW-H with Fe(III) ions further increased to 0.51 μmol/L, indicating that the growth inhibition was correlated with the increased RCS levels. …"

Expression changes of metalloproteinase (MMP)-9 and tissue inhibitor of matrix metalloproteinase (TIMP)-1 in immunofluorescence (IF) staining. حسب Minyan Sun (19751378)

"…IF staining showed that MMP-9 expression was significantly increased in the model group. After treatment with QLQX or empagliflozin, the expression of MMP-9 significantly decreased. …"

5.HT_1A binding difference between known cause of death (KCOD) controls and SIDS. حسب Hannah C. Kinney (10280975)

"…A) When SIDS is compared to PostKCOD controls only, the hypoglossal nucleus (HG) shows a significant increase in binding in SIDS compared to controls while the nucleus of the solitary tract (NTS) and medial accessory olive (MAO) show a significant age-vs-diagnosis interaction. …"

Effects of vidarabine, V2E, V3E and V5E on AC activity in the heart of WT and AC5KO mice. حسب Kenji Suita (750993)

Participants baseline characteristics. حسب Shenghang Wang (21213000)

"…The clinical trial’s results showed that MMF treatment had a positive effect on the improvement of BMD in the lumbar spine and increased serum P1NP levels while decreased β-CTX levels. …"

Flowchart of the clinical trial. حسب Shenghang Wang (21213000)

"…The clinical trial’s results showed that MMF treatment had a positive effect on the improvement of BMD in the lumbar spine and increased serum P1NP levels while decreased β-CTX levels. …"

The components of Qili Qiangxin capsule. حسب Minyan Sun (19751378)

"…QLQX treatment for 28 days significantly improved cardiac function, as evidenced by decreases in heart mass index, cardiac volume, left ventricular end-diastolic diameter, left ventricular end-systolic diameter, N-terminal B-type natriuretic peptide levels, and high-sensitivity cardiac troponin I levels and increases in left ventricular ejection fraction and left ventricular fraction shortening. …"

Effects of vidarabine, V2E, V3E and V5E on cardiac fibrosis. حسب Kenji Suita (750993)

"…(B) Chronic ISO infusion significantly increased the area of fibrosis in cardiac muscle but this increase was significantly decreased by Vida, V2E, V3E and V5E. …"

Effect of overexpressing <i>CEBPB</i> and <i>GFI-1</i> on <i>SOST</i> expression. حسب Avneesh Chopra (20927514)

"…<p><b>(A)</b> Overexpression of the <i>CEBPB</i>-LAP2 isoform reduced <i>SOST</i> expression in SaOS-2 cells. Significantly increased LAP2 and LIP expression 48 h after transfection of the corresponding overexpression plasmids (<b>left panel</b>). …"